Fortis Healthcare Limited
All news and filings related to Fortis Healthcare Limited.
View all news & filings- Low impact
Fortis Healthcare Schedules Investor Meetings on April 27-28, 2026
Fortis Healthcare will hold investor and analyst meetings on April 27-28, 2026, in Mumbai. Organized by JM Financial, the meetings will cover general business and industry updates. No UPSI will be disclosed.
Read the summary - Low impact
Fortis Healthcare Limited Files SEBI Disclosure for FY26 Bonds
Fortis Healthcare Limited filed its SEBI disclosure for FY26 bonds on April 10, 2026. The company detailed listing and credit rating information for its non-convertible securities. All interest payments were made on schedule, with no defaults reported.
Read the summary - Low impact
Fortis Healthcare Reports Debt Securities Details as of March 31, 2026
Fortis Healthcare Limited reported details of its listed debt securities as of March 31, 2026. Three issuances totaling ₹1,550 Crore are outstanding, with coupon rates of *7.7648%* p.a. for the first year, subject to annual resets. The information was submitted to NSE and BSE.
Read the summary - Low impact
Fortis Healthcare Files SEBI Compliance Certificate for Q4 FY26
Fortis Healthcare Limited submitted a certificate for the quarter ended March 31, 2026, as per SEBI regulations. The company's Registrar and Transfer Agent, Kfin Technologies Limited, confirmed that dematerialization/rematerialization details were provided to stock exchanges.
Read the summary - Medium impact
Fortis Healthcare Subsidiary Receives ₹149 Crore Income Tax Demand for AY 2021-22
Fortis Healthcare's subsidiary, Fortis Hospitals Limited, received an Income Tax Order for AY 2021-22, raising a demand of ₹149.12 Crores. The company is evaluating options to appeal the order.
Read the summary - Medium impact
Fortis Healthcare Subsidiary Receives ₹117 Crore Tax Demand Order
Fortis Healthcare's subsidiary, Fortis Hospitals Limited, received an Income Tax Order on March 27, 2026, raising a demand of ₹117.04 Crores for AY 2024-25. The company is evaluating options including filing an appeal and rectification.
Read the summary - Low impact
Fortis Healthcare Closes Trading Window from April 1, 2026
Fortis Healthcare Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2026.
Read the summary - Medium impact
Fortis Healthcare Employees Stock Option Scheme 2026 Approved
Fortis Healthcare Limited's Employees Stock Option Scheme 2026 and associated grants to subsidiary and associate company employees have been approved via postal ballot. The resolutions passed with significant majority through e-voting. The voting concluded on March 18, 2026.
Read the summary - Medium impact
Fortis Healthcare Shareholders Approve Employee Stock Option Scheme
Fortis Healthcare shareholders overwhelmingly approved the Employees Stock Option Scheme 2026 and the grant of options to employees of subsidiaries and associates. The resolutions passed with significant majorities through postal ballot and e-voting, which concluded on March 18, 2026.
Read the summary - Low impact
Fortis Healthcare Reports NIL Transfer Requests for Physical Shares in Jan-Feb 2026
Fortis Healthcare Limited reported NIL transfer requests for physical shares for January and February 2026. The company's Registrar and Share Transfer Agent confirmed no requests were received, processed, or approved under the SEBI special window during these months.
Read the summary - Medium impact
Fortis Healthcare's Merger Scheme Effective March 1, 2026, Post NCLT Order Filing
Fortis Healthcare Limited's merger scheme is effective March 1, 2026. The scheme involves the absorption of subsidiaries Fortis Emergency Services, Fortis Cancer Care, Fortis Health Management (East), and Birdie & Birdie Realtors into Fortis Hospitals Limited. The NCLT order was filed with the Registrar of Companies on March 1, 2026.
Read the summary - High impact
Fortis Healthcare Q3 FY26: Revenue up 17.5% to ₹2,265 Cr, EBITDA surges 34.8%
Fortis Healthcare reported Q3 FY26 consolidated revenue of ₹2,265 Cr, up 17.5%. EBITDA grew 34.8% to ₹505 Cr, with margins at 22.3%. The company acquired People Tree Hospital in Bengaluru for ₹430 Cr and launched Adayu mental health facility. Agilus Diagnostics revenue rose 8.3% to ₹371 Cr with EBITDA at ₹86 Cr.
Read the summary - Medium impact
Fortis Healthcare: NTK Files Petition to Amend Claim Against Daiichi Sankyo
Fortis Healthcare Limited updated on litigation where NTK, a promoter shareholder, filed a petition to amend its claim against Daiichi Sankyo in the Tokyo District Court on February 12, 2026. The amendment focuses on preventing Daiichi Sankyo from obstructing acquisitions and corporate exercises through defamatory statements.
Read the summary - Low impact
Fortis Healthcare Publishes Newspaper Advertisements Regarding Postal Ballot Notice
Fortis Healthcare Limited has published newspaper advertisements on February 17, 2026, in Financial Express and Rozana Spokesman. The ads inform members about the completion of electronic transmission of the Postal Ballot Notice and Form, in compliance with SEBI regulations.
Read the summary - Low impact
Fortis Healthcare Releases Q3FY26 Earnings Call Audio Recording
Fortis Healthcare released the audio recording of its Q3FY26 earnings call, held on February 16, 2026. The call discussed the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The recording is available on the company's investor website.
Read the summary - Medium impact
Fortis Healthcare Seeks Shareholder Approval for Employees Stock Option Scheme 2026
Fortis Healthcare Limited is seeking shareholder approval for its ESOP 2026. The scheme proposes to issue up to 1,50,99,163 employee stock options. Shareholders can vote via postal ballot or e-voting, with the remote e-voting period from February 17 to March 18, 2026.
Read the summary - Medium impact
Fortis Healthcare Seeks Shareholder Approval for ESOP Scheme 2026
Fortis Healthcare is seeking shareholder approval for its Employees Stock Option Scheme 2026. The scheme allows for the grant of up to 1,50,99,163 stock options to employees of the company and its subsidiaries/associates. Voting is open from February 17 to March 18, 2026.
Read the summary - Low impact
Fortis Healthcare Publishes Un-Audited Financial Results for Q3 FY26
Fortis Healthcare Limited published its un-audited financial results for the quarter and period ended December 31, 2025. The results were announced via newspaper publications on February 14, 2026. Full details are available on the stock exchange and company websites.
Read the summary - Medium impact
Fortis Healthcare Board Approves Q3 FY26 Results and New ESOP Scheme
Fortis Healthcare's Board approved Q3 FY26 results and a new ESOP 2026 scheme. The ESOP 2026 allows for the grant of 1,50,99,163 options, exercisable into equity shares of ₹10 face value. The exercise price will be the market price, not less than the face value. Revisions to the Related Party Transaction Policy were also approved.
Read the summary - High impact
Fortis Healthcare Q3 FY26: Revenue up 17.5% to ₹2,265 Cr, EBITDA surges 34.8%
Fortis Healthcare's Q3 FY26 consolidated revenue rose 17.5% YoY to ₹2,265 Cr. Operating EBITDA surged 34.8% to ₹505 Cr, with margins at 22.3%. The hospital business revenue grew 19.4% to ₹1,938 Cr. The company acquired People Tree Hospital for ₹430 Cr and launched a mental health facility.
Read the summary - High impact
Fortis Healthcare Q3 FY26 Revenue Up 17.5% to ₹2,265 Cr, EBITDA Rises 34.8%
Fortis Healthcare reported Q3 FY26 consolidated revenues of ₹2,265 crore, up 17.5% YoY. Operating EBITDA increased 34.8% to ₹505 crore, with margins at 22.3%. Hospital revenues grew 19.4% to ₹1,938 crore. The company acquired People Tree Hospital in Bengaluru for ₹430 crore and launched a mental health facility.
Read the summary - Medium impact
Fortis Healthcare Board Approves Q3 FY26 Results & New ESOP Scheme
Fortis Healthcare's Board approved Q3 FY26 results and a new ESOP 2026 scheme. The ESOP 2026 involves a pool of 1,50,99,163 options, exercisable at market price. The company also revised its Related Party Transaction Policy.
Read the summary - Medium impact
Fortis Healthcare Board Approves Q3 FY26 Results and New ESOP Scheme
Fortis Healthcare's Board approved Q3 FY26 standalone and consolidated financial results. The company also approved the 'Fortis Healthcare Limited Employee Stock Option Scheme 2026' (ESOP 2026), which includes a pool of 1,50,99,163 stock options. The Board also approved revisions to the Related Party Transaction Policy.
Read the summary - Low impact
Fortis Healthcare to Host Q3FY26 Post-Results Conference Call on Feb 16, 2026
Fortis Healthcare Limited will hold a virtual conference call on February 16, 2026, at 11:00 am IST to discuss its unaudited Q3FY26 and 9MFY26 financial results. Dial-in details and a replay option are available. No UPSI will be disclosed.
Read the summary - Medium impact
Fortis Healthcare Shareholders Approve Appointment of New Director
Fortis Healthcare Limited shareholders approved the appointment of Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director through postal ballot and e-voting. The resolution passed with 99.39% votes in favor. The voting concluded on January 22, 2026.
Read the summary - Medium impact
Fortis Healthcare Appoints Mohd Shahazwan Bin Mohd Harris as Director
Fortis Healthcare Limited has appointed Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. The appointment was approved via postal ballot and e-voting, with the resolution passing on January 22, 2026. Over 99% of votes were in favour of the appointment.
Read the summary - Medium impact
Fortis Healthcare: Delhi High Court Orders Inquiry in Perjury Case Against Third Party
Fortis Healthcare Limited announced that the Delhi High Court has ordered an inquiry into a perjury case filed by the company against a third party and its officers for submitting a false affidavit. The court's decision was made on January 21, 2026. The company has stated that this development has no expected financial implications.
Read the summary - Medium impact
Fortis Healthcare subsidiary merger approved by NCLT, effective date April 1, 2022
Fortis Healthcare's composite merger scheme involving four wholly-owned subsidiaries has been approved by NCLT on January 5 and January 16, 2026. The appointed date for the scheme is April 1, 2022. The merger aims for operational efficiencies and cost rationalization through simplification of management structure.
Read the summary - Medium impact
Fortis Healthcare: NCLT Approves Merger Scheme for Subsidiaries
Fortis Healthcare's subsidiaries merger into Fortis Hospitals Limited approved by NCLT. The scheme aims for operational efficiencies and cost reduction. The appointed date is April 1, 2022. No cash consideration or share exchange will occur.
Read the summary - Medium impact
Fortis Healthcare Subsidiary Completes Acquisition of TMI Healthcare
Fortis Healthcare's subsidiary, International Hospital Limited, has successfully completed the acquisition of TMI Healthcare Private Limited. The transaction includes hospital operations, land, and building. This consummation follows earlier definitive agreements.
Read the summary - Low impact
Fortis Healthcare to Present at JP Morgan 2026 Healthcare Conference
Fortis Healthcare Limited will present at the JP Morgan 2026 Healthcare Conference in the USA from January 12-15, 2026. An investor presentation titled “Non-Deal Roadshow / JP Morgan 2026 Healthcare Conference” will be used for interactions with investors and analysts. The presentation will be available on the company's website.
Read the summary - Low impact
Fortis Healthcare Announces Investor Meetings in New York, Boston, and San Francisco
Fortis Healthcare Limited announced upcoming investor meetings with management to discuss business and industry updates. Meetings are scheduled for January 12-13, 2026, in New York and Boston, and January 15, 2026, in San Francisco as part of the J.P. Morgan Healthcare Conference.
Read the summary - Low impact
Fortis Healthcare Schedules Investor Meetings in New York, Boston, and San Francisco
Fortis Healthcare Limited will hold investor meetings in New York, Boston, and San Francisco from January 12-15, 2026. These meetings, including a J.P. Morgan roadshow and healthcare conference, aim to provide general business and industry updates. No UPSI will be shared.
Read the summary - Low impact
Fortis Healthcare Schedules Investor Meetings in New York, Boston, and San Francisco
Fortis Healthcare Limited has scheduled investor meetings in New York, Boston, and San Francisco from January 12-15, 2026. The company will engage in one-on-one and group meetings to discuss general business updates and the industry. No UPSI will be shared during these interactions.
Read the summary - High impact
Fortis Healthcare Ratings Reaffirmed by CRISIL AA+/Stable/A1+
CRISIL Ratings has reaffirmed Fortis Healthcare Limited's ratings at ‘Crisil AA+/Stable/Crisil A1+’. The company's consolidated revenue grew 17% to ₹4,498 crore in H1FY26, with operating margin improving to 23.3%. FHL plans to add 1,200-1,500 beds by FY28 and is undertaking acquisitions totaling over ₹830 crore.
Read the summary - Low impact
Fortis Healthcare: Certificate under SEBI Reg 74(5) for Q3 FY26
Fortis Healthcare Limited has submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The company's Registrar and Transfer Agent, Kfin Technologies Limited, confirmed that details of securities dematerialization/rematerialization have been furnished to stock exchanges.
Read the summary - Low impact
Fortis Healthcare Subsidiary Receives GST Order for ₹597.93 Lakhs Demand
Fortis Healthcare's subsidiary received a GST order confirming a demand of ₹597.93 lakhs (including ₹259.32 lakhs penalty and ₹79.29 lakhs interest). The company believes the demand is not maintainable and is filing an appeal, anticipating no material impact on its operations or financials.
Read the summary - Low impact
Fortis Healthcare Subsidiary Receives GST Order for ₹5.98 Crore Demand
Fortis Healthcare's subsidiary, Fortis Health Management Limited, received a GST order confirming a demand of ₹5.98 crore, including ₹2.59 crore penalty and ₹79.29 lakh interest. The company disputes the demand and plans to appeal, expecting no significant financial impact.
Read the summary - Medium impact
Fortis Healthcare Subsidiary Receives GST Order; Company Plans Appeal
Fortis Healthcare's subsidiary received a GST order for ₹597.93 lakhs, including ₹259.32 lakhs penalty. The company believes the demand is not maintainable and is filing an appeal, expecting no significant financial impact.
Read the summary - Medium impact
Fortis Healthcare receives GST orders totaling ₹2149.61 Lakhs
Fortis Healthcare has received GST orders confirming demands totaling ₹2149.61 lakhs across FY 2020-21, FY 2021-22, and FY 2022-23. These amounts include interest and penalties. The company's response led to the confirmation of these demands by the GST Authority.
Read the summary - Medium impact
Fortis Healthcare receives GST orders totaling ₹2149.61 Lakhs
Fortis Healthcare received GST orders for FY 2020-21, 2021-22, and 2022-23. The total confirmed demand, including interest and penalty, amounts to ₹478.08 lakhs, ₹850.00 lakhs, and ₹811.53 lakhs respectively. Show cause notices for the remaining amounts were dropped.
Read the summary - Medium impact
Fortis Healthcare Faces GST Orders Totaling ₹21.49 Crore
Fortis Healthcare received GST orders for FY21, FY22, and FY23. The confirmed demands, including interest and penalties, total ₹4.78 crore for FY21, ₹8.50 crore for FY22, and ₹8.12 crore for FY23, amounting to a total of ₹21.40 crore. Show cause notices for remaining amounts were dropped.
Read the summary - Medium impact
Fortis Healthcare faces GST demands totaling ₹21.7 Crores for FY21-23
Fortis Healthcare received GST orders confirming demands totaling ₹21.70 crore (₹4.78 crore for FY21, ₹8.50 crore for FY22, ₹8.12 crore for FY23) including interest and penalties. Show cause notices for the remaining amounts were dropped.
Read the summary - Low impact
Fortis Healthcare receives GST orders totaling ₹21.49 crore for FY21-23
Fortis Healthcare received GST orders for FY21-23, totaling ₹21.49 crore. This includes demands, interest, and penalties for FY20-21 (₹4.78 crore), FY21-22 (₹8.50 crore), and FY22-23 (₹8.12 crore). Some show cause notices were dropped.
Read the summary - Medium impact
Fortis Healthcare Faces GST Orders for FY21-23, Totaling ₹2149.64 Cr
Fortis Healthcare received GST orders for FY21-23. Confirmed demands total ₹2149.64 lakhs, including interest and penalties. The orders pertain to fiscal years 2020-21, 2021-22, and 2022-23. The company has been issued notices by the State Tax Officer, Tamil Nadu.
Read the summary - Low impact
Fortis Healthcare Completes Postal Ballot Notice Transmission
Fortis Healthcare has completed the electronic transmission of its Postal Ballot Notice to members. E-voting is open from December 24, 2025, to January 22, 2026. Results will be declared by January 27, 2026. Mr. Mukesh Agarwal is the appointed Scrutinizer.
Read the summary - Low impact
Fortis Healthcare seeks member approval for Mohd Shahazwan Bin Mohd Harris's director appointment
Fortis Healthcare is seeking member approval for the appointment of Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. Voting will be conducted via postal ballot and e-voting from December 24, 2025, to January 22, 2026. Mr. Harris has over 25 years of experience in investments and strategy.
Read the summary - Medium impact
Fortis Healthcare seeks shareholder nod for Mohd Shahazwan's director appointment
Fortis Healthcare is seeking shareholder approval to appoint Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. The postal ballot process is underway, with voting open from December 24, 2025, to January 22, 2026. Mr. Harris brings over 25 years of experience in investments and strategy.
Read the summary - Low impact
Fortis Healthcare Wins Civil Suit in Delhi High Court
Fortis Healthcare Limited has won a civil suit filed against a third party in the Hon’ble High Court of Delhi. The court ruled in favor of the company on December 19, 2025. The company stated there are no expected financial implications or impact on its financial position.
Read the summary - Low impact
Fortis Healthcare Makes Interest Payments on Debentures
Fortis Healthcare Limited made interest payments totaling ₹40.64 crore, ₹42.78 crore, and ₹47.06 crore on December 22, 2025, for three series of debentures. The payments were made annually, with a record date of December 5, 2025.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio